Physician Data Query

Last uploaded: January 31, 2024
Preferred Name

finasteride

Synonyms

(5alpha,17beta)-N-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide

Definitions

A synthetic 4-azasteroid compound. Finasteride competitively binds to and inhibits steroid type II 5-alpha-reductase in the prostate gland, liver, and skin, thereby interfering with the enzymatic conversion of testosterone to 5-dihydrotestosterone (DHT) and reducing serum DHT levels. The reduction in serum DHT levels results in diminished stimulation of androgen receptors in the nuclei of prostate cells and, so, diminished prostate cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1099" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1099" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000041096

altLabel

(5alpha,17beta)-N-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide

Finastid

Proscar

MK 906

Pro-Cure

MK-906

Prostide

Uprosan

Chibro-Proscar

Component of

http://purl.bioontology.org/ontology/PDQ/CDR0000043049

cui

C1517188

C0060389

C0733735

C0678149

C1831595

C1517192

C1517190

C1517189

Date last modified

2008-10-14

definition

A synthetic 4-azasteroid compound. Finasteride competitively binds to and inhibits steroid type II 5-alpha-reductase in the prostate gland, liver, and skin, thereby interfering with the enzymatic conversion of testosterone to 5-dihydrotestosterone (DHT) and reducing serum DHT levels. The reduction in serum DHT levels results in diminished stimulation of androgen receptors in the nuclei of prostate cells and, so, diminished prostate cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1099" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1099" NCI Thesaurus)

Legacy PDQ ID

4136

LT

TRD

NCI ID

C1099

notation

CDR0000041096

ORIG STY

Drug/agent

prefLabel

finasteride

tui

T125

T109

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/MESH/D018120 MESH CUI
http://purl.bioontology.org/ontology/SCTSPA/386963006 SCTSPA CUI
http://purl.bioontology.org/ontology/CSP/4007-0045 CRISP CUI
http://purl.bioontology.org/ontology/RCD/x02oZ RCD CUI
http://purl.bioontology.org/ontology/SCTSPA/109035006 SCTSPA CUI
http://purl.bioontology.org/ontology/NDFRT/N0000007142 NDFRT CUI
http://purl.bioontology.org/ontology/MSHFRE/D018120 MSHFRE CUI
http://purl.bioontology.org/ontology/CSP/4007-0045 CRISP CUI
http://purl.bioontology.org/ontology/LNC/MTHU036233 LOINC CUI
http://purl.bioontology.org/ontology/NDFRT/N0000148118 NDFRT CUI
http://purl.bioontology.org/ontology/LNC/LP101034-9 LOINC CUI
http://purl.bioontology.org/ontology/ATC/G04CB01 ATC CUI
http://purl.bioontology.org/ontology/SNOMEDCT/109035006 SNOMEDCT CUI
http://purl.bioontology.org/ontology/RXNORM/25025 RXNORM CUI
http://purl.bioontology.org/ontology/RCD/fi6.. RCD CUI
http://purl.bioontology.org/ontology/VANDF/4020167 VANDF CUI
http://purl.bioontology.org/ontology/SNOMEDCT/386963006 SNOMEDCT CUI
http://purl.bioontology.org/ontology/NDDF/003665 NDDF CUI
http://purl.bioontology.org/ontology/MESH/D018120 MESH CUI
http://purl.bioontology.org/ontology/ATC/D11AX10 ATC CUI
http://purl.bioontology.org/ontology/MESH/D018120 MESH CUI
http://purl.bioontology.org/ontology/CSP/4007-0045 CRISP CUI
http://purl.bioontology.org/ontology/RXNORM/196476 RXNORM CUI
http://purl.bioontology.org/ontology/MESH/D018120 MESH CUI
http://purl.obolibrary.org/obo/CHEBI_5062 CHEBI LOOM
http://purl.obolibrary.org/obo/MESH_D018120 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_5062 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_5062 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_5062 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_5062 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_5062 GSSO LOOM
http://purl.obolibrary.org/obo/CHEBI_5062 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_5062 NIFSTD LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#14023 OCHV LOOM
http://stirdf.jst.go.jp/id/200907039784114108 IOBC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D04.808.925.100.250 RH-MESH LOOM
http://www.drugbank.ca/drugs/DB01216 FTC LOOM
http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#finasteride PCAO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0060389 OCHV LOOM
http://www.co-ode.org/ontologies/galen#Finasteride GALEN LOOM
http://purl.bioontology.org/ontology/CSP/4007-0045 CRISP LOOM
http://purl.obolibrary.org/obo/NCIT_C1099 BERO LOOM
http://purl.bioontology.org/ontology/LNC/MTHU036233 LOINC LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148118 NDFRT LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1099 NCIT LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D018120 RH-MESH LOOM
http://purl.bioontology.org/ontology/LNC/LP101034-9 LOINC LOOM
http://purl.bioontology.org/ontology/ATC/G04CB01 ATC LOOM
https://go.drugbank.com/drugs/DB01216 MDM LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D04.808.054.079.500 RH-MESH LOOM
http://purl.obolibrary.org/obo/OMIT_0018360 OMIT LOOM
http://purl.jp/bio/4/id/200906097333977605 IOBC LOOM
http://purl.bioontology.org/ontology/RXNORM/25025 RXNORM LOOM
http://purl.bioontology.org/ontology/RCD/fi6.. RCD LOOM
http://purl.bioontology.org/ontology/VANDF/4020167 VANDF LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386963006 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/NDDF/003665 NDDF LOOM
http://purl.bioontology.org/ontology/MESH/D018120 MESH LOOM
http://www.phoc.org.cn/pmo/class/PMO_00018540 PMAPP-PMO LOOM
http://purl.bioontology.org/ontology/ATC/D11AX10 ATC LOOM